Investorideas.com - Cannabis Stock News: 1933 Industries (CSE: TGIF) (OTCQX: TGIFF) Reports First Quarter Financial Results for Fiscal Year 2020
www.investorideas.com - news that inspires big ideas
Tuesday, 31 December 2019
Monday, 30 December 2019
Investorideas.com - Cannabis Stock News: Khiron (TSXV: KHRN) (OTCQB: KHRNF) Welcomes Colombia's Receipt of 2020 Production Quota of 56.5 Tons of High-THC Cannabis
Investorideas.com - Cannabis Stock News: Khiron (TSXV: KHRN) (OTCQB: KHRNF) Welcomes Colombia's Receipt of 2020 Production Quota of 56.5 Tons of High-THC Cannabis
www.investorideas.com - news that inspires big ideas
www.investorideas.com - news that inspires big ideas
Investor Ideas Potcasts; Cannabis News and Stocks on the Move; (CSE: $BEV.C), (NASDAQ: $AMRS), (TSXV: $KHRN.V), (CSE: $OILS.C), (TSX: $APHA.TO) (NYSE: $APHA)
Investor
Ideas Potcasts; Cannabis News and Stocks on the Move; (CSE: $BEV.C), (NASDAQ: $AMRS), (TSXV: $KHRN.V),
(CSE: $OILS.C), (TSX: $APHA.TO) (NYSE: $APHA)
Delta, Kelowna, BC, December 30, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/12301BEV-AMRS-KHRN-OILS-APHA.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
BevCanna
Enterprises Inc. (CSE:BEV) (OTCQB:
BVNNF) announced that is
has increased the size of its outdoor cannabis cultivation site to 292 acres,
up from the originally announced 130 acre site. BevCanna has partnered with
agricultural experts Clearwater CannGrow Ltd. to grow certified organic
sun-grown cannabis on the property near Osoyoos, British Columbia.
This
expansion of cultivatable land will allow BevCanna to develop into one of
largest outdoor cannabis cultivators in Canada. The Company has in turn
increased its anticipated production to 300,000 kg - 400,000 kg of biomass, and
a yield of 30,000 kg – 40,000 kg of pure cannabinoids through the finished extract.
"Interest
in our BC sun grown cannabis has been exceptionally strong, and we're expanding
our cultivation and production capabilities to meet the anticipated
demand," said John Campbell, Chief Strategy Officer at BevCanna. "The
increased capacity will position BevCanna well to become a leader in the
production of high-quality, next-generation products, in the lead-up to
Canada's commercialization of such products in 2020."
In
conjunction with the additional cultivation capacity, BevCanna has completed a
debt settlement with cultivation partner Clearwater CannGrow, in the amount of
$500,000, in exchange for the issuance of 1,000,000 common shares at a deemed
price of $0.50 per Share.
"We're
very pleased to further strengthen our relationship with Clearwater
CannGrow," said John Campbell, Chief Strategy Officer at BevCanna.
"Clearwater CannGrow's direct expenditures into our agricultural operation
are an incredible sign of confidence and commitment to the operation, and to
BevCanna as a whole."
The
Shares issued in the debt settlement are subject to resale restrictions imposed
by applicable law or regulation, including a statutory hold period expiring
four months and one day from the date of closing of the debt settlement.
Amyris, Inc. (NASDAQ:
AMRS), a leader in the development and production of
sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors
& Fragrances markets, reported that it
has successfully shipped the first cannabinoid to its partner, LAVVAN. Amyris
is also well on its way to the shipment of a second cannabinoid in the first
half of 2020.
These
ingredients are produced with Amyris's fermentation technology platform
delivering the leading quality and high purity at a significantly reduced cost
relative to cannabis plant grown and derived ingredients. The company's
technology allows Amyris to scale ingredients that are rarer within the
cannabis plant, and difficult and extremely expensive to extract in quantity.
This is the 10th unique fermentation molecule Amyris has currently
in production. Amyris is a market leader in Clean Beauty and natural
ingredients from fermentation and currently has 22 additional molecules in
development with some of the world's leading companies as partners and
long-term supply and commercialization agreements to ensure successful market
entry.
The
company also announced that it has agreed on business terms for a partnership
with a leading Asian pharmaceutical company to develop and scale a breakthrough
target for a rare oncology treatment. In addition to the success in
cannabinoids and the new opportunity in oncology the company has also agreed to
significantly expand its current collaboration with its Chinese partner for
vitamins. Amyris plans to provide further details on these agreements at an
investor update meeting to be scheduled in February. These new agreements
represent several millions of dollars in collaboration payments annually for
the next several years. Biossance is also having an excellent quarter with Biossance.com now
representing about 50% of Biossance revenue and Sephora continuing to deliver
excellent growth.
"We
are very pleased to end 2019 with strong operational performance and business
momentum," said John Melo, President and CEO of Amyris. "We plan to
continue building on our position as the leading synthetic biology company by
continuing to deliver the highest purity and most sustainably sourced
ingredients for the Health, Beauty and Flavor and Fragrance industries. Our
brands are delivering the leading products in their respective categories and
this is helping us deliver an excellent quarter. We expect to have our
financing needs behind us early in 2020 and a strong year of profitable
growth."
Khiron Life
Sciences Corp. (TSXV:
KHRN) (OTCQB:
KHRNF) welcomed the
Colombian government's announcement that the country has been awarded a record
high quota of 21.84% of worldwide high -THC for commercial and scientific
purposes. The quota, which is awarded by the International Narcotics Control
Board ("INCB"), an independent body for the implementation of the
United Nations Drug Convention, affirms Colombia's role as one of the most
important supply sources for the licensed global cannabis economy.
Established
in 1961, the INCB, who's members are made up of global government agencies and
representatives of the World Health Organization, plays an important role in
monitoring enforcement of restrictions on narcotics and psychotropics and in
deciding which jurisdictions should be regulated. The quota allocation of 56.5
tons of dry flower for Colombia in 2020, affirms that the international
community governing legalized narcotics recognizes the important work of the
Colombia government in establishing an effective regulatory framework to
support national and worldwide cannabis demand.
Juan
Diego Alvarez, Khiron Vice President of Regulatory Affairs, stated "As the
only company with an authorized high-THC quota for cultivation in 2019 to meet
the needs of patients in Colombia, we welcome the INCB announcement and
congratulate the Government of Colombia on the achievement. The 2020 quota
guarantees access to new medical products that can transform patients'
lives."
Khiron
Life Sciences is currently the only cannabis company in Colombia with an
allocation of quota to manufacture psychoactive medical cannabis for commercial
domestic purposes, and one of the few companies also authorized to meet export
demand. As previously announced, the authorization is a result of commercial
quotas allocated to Khiron by the Colombian Technical Quotas Group
("TQG"), which permit the Company to cultivate and commercialize up
to 560 kg – or approximately, 65,000 units – of psychoactive, high-THC cannabis
in 2019. As of April 2019, Khiron has applied for additional commercial quotas
for high-THC cannabis for 2020. TQG decisions on commercial quotas for the year
are anticipated to be announced by February 2020.
Nextleaf Solutions
Ltd.
(CSE:
OILS) (OTCQB:
OILFF) announced that
the Canadian Intellectual Property Office has granted the Company a patent for
its proprietary filtration stack used in the post-extraction processing of THC
and CBD oils. Nextleaf has been issued a total of 11 patents by four
international patent offices in the key markets of Canada, the United States of
America, Australia, and Colombia.
"Given
the abundant supply of lower-grade dried cannabis, we believe processors that
establish a competitive advantage by utilizing superior technology to transform
otherwise unsellable biomass into high-purity THC and CBD oils at a lower cost
than competitors, will generate better margins and build a sustainable long
term business," said Paul Pedersen, CEO of Nextleaf Solutions. "As we
close out 2019, I'm extremely proud of our R&D team for obtaining its 11th
patent, protecting what we believe to be the most efficient methods for
producing distilled THC and CBD oil at scale within a regulated
environment," continued Pedersen.
Aphria Inc. (TSX:
APHA) (NYSE:
APHA) will
release their financial results for its second quarter and six
months ended November 30, 2019 on January 14, 2020 before market open.
Aphria
executives will host a conference call to discuss these results at 8:00 am
Eastern Time. To listen to the live call, dial (888) 231-8191 from Canada and
the U.S. or (647) 427-7450 from International locations and use the passcode
1575423. A telephone replay will be available approximately two hours after the
call concludes through January 28, 2020. To access the recording dial (855)
859-2056 and use the passcode 1575423.
There
will also be a simultaneous, live webcast available on the Investors section of
Aphria's website at aphriainc.com. The
webcast will be archived for 30 days.
Investor ideas
reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...